to observe and evaluate the clinical efficacy and safety of continuous use of ofs for premenopausal patients with early breast cancer after 5 years

Showing 1 - 1 of 1

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

To Observe and Evaluate the Clinical Efficacy and Safety of Continuous Use of OFS for Premenopausal Patients With Early Breast

Active, not recruiting
  • To Observe and Evaluate the Clinical Efficacy and Safety of Continuous Use of OFS for Premenopausal Patients With Early Breast Cancer After 5 Years
  • OFS continues to use group after 5 years
  • Immunohistochemical detection of HR status
  • Wuhan, Hubei, China
    Wu Xinhong
Sep 17, 2023